Literature DB >> 27384868

Serum IL-4 and IL-10 Levels Correlate with the Symptoms of the Drug-Naive Adolescents with First Episode, Early Onset Schizophrenia.

Şeref Şimşek1, Veli Yıldırım2, Abdullah Çim3, Savaş Kaya4.   

Abstract

OBJECTIVE: In this study, it was aimed to understand the underlying possible immunopathogenesis of first episode, early onset schizophrenia (EOS) through profiling the T helper 1 (Th1) cell cytokines TNF-α, IFN-γ, and IL-2, Th2 cell cytokines IL-4 and IL-10, Th17 cell cytokine IL-17A, and inflammatory cytokine IL-6.
METHODS: The study included a total of 30 children, admitted to child psychiatry outpatient clinic aged between 10 and 17 years of age, who had not received prior therapy and were diagnosed with psychosis according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) as the patient group, and 26 age- and gender-matched children as the control group. Structured psychiatric interviews (K-SADS-PL and PANSS) were conducted with all participants. The BD Cytokine Bead Array Human Th1/Th2/Th17 Cytokine Kit is used for the measurement of serum cytokines, for example, IL-2, IL-4, IL-6, IL-10, IL-17A, TNF-α, and IFN-γ.
RESULTS: There was no significant difference between groups in terms of IL-2, IL-4, IL-6, IL-10, IL-17A, TNF-α, and IFN-γ levels (p > 0.05). However, there was a significant correlation between IL-10 and IL-4 with negative symptoms of EOS (r = -0.65, p = 0.02 and r = 0.67, p = 0.02, respectively).
CONCLUSION: IL4 and IL-10 levels have a relationship with negative symptoms of disease. Therefore, this study might suggest that immunological processes might have a role in the disease pathophysiology.

Entities:  

Keywords:  IL-17A; cytokine; early-onset schizophrenia; first episode psychosis

Mesh:

Substances:

Year:  2016        PMID: 27384868     DOI: 10.1089/cap.2015.0220

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  12 in total

1.  Interleukin-17 Alteration in First-Episode Psychosis: A Meta-Analysis.

Authors:  Xinyu Fang; Yi Zhang; Weixing Fan; Wei Tang; Chen Zhang
Journal:  Mol Neuropsychiatry       Date:  2017-10-28

2.  Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine.

Authors:  Xiaoping Yuan; Song Wang; Yudong Shi; Yating Yang; Yulong Zhang; Lei Xia; Kai Zhang; Huanzhong Liu
Journal:  Psychopharmacology (Berl)       Date:  2022-01-26       Impact factor: 4.530

3.  Reduced regulatory T cells with increased proinflammatory response in patients with schizophrenia.

Authors:  Cigdem Sahbaz; Noushin Zibandey; Ayse Kurtulmus; Yazgul Duran; Muazzez Gokalp; Ismet Kırpınar; Fikrettin Sahin; Sinan Guloksuz; Tunc Akkoc
Journal:  Psychopharmacology (Berl)       Date:  2020-03-27       Impact factor: 4.530

4.  A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis.

Authors:  Toby Pillinger; Emanuele F Osimo; Stefan Brugger; Valeria Mondelli; Robert A McCutcheon; Oliver D Howes
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

5.  Alterations of plasma cytokine biomarkers for identifying age at onset of schizophrenia with neurological soft signs.

Authors:  Jia-Yun Liu; Han-Yu Chen; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Sheng-Hsiang Lin
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738

Review 6.  Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Alberto Rodríguez-Quiroga; Celso Arango
Journal:  Int J Neuropsychopharmacol       Date:  2017-06-01       Impact factor: 5.176

Review 7.  Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  Front Psychiatry       Date:  2017-10-25       Impact factor: 4.157

8.  Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia.

Authors:  Nuno Trovão; Joana Prata; Orlando VonDoellinger; Susana Santos; Mário Barbosa; Rui Coelho
Journal:  Psychiatry Investig       Date:  2019-03-07       Impact factor: 2.505

Review 9.  Cytokine Alterations in Schizophrenia: An Updated Review.

Authors:  Sara Momtazmanesh; Ameneh Zare-Shahabadi; Nima Rezaei
Journal:  Front Psychiatry       Date:  2019-12-06       Impact factor: 4.157

10.  Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients.

Authors:  Junwei Yan; Yuanyuan Chen; Peijun Ju; Jianliang Gao; Loufeng Zhang; Jingwei Li; Keming Wang; Jie Zhang; Chao Li; Qingrong Xia; Cuizhen Zhu; Xulai Zhang
Journal:  Front Psychiatry       Date:  2022-02-22       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.